Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia-Reference-Cited by-同舟云学术

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

Published:2013-03-14 Issue:11 Volume:121 Page:1976-1981
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Gudbrandsdottir Sif¹²,Birgens Henrik Sverre³,Frederiksen Henrik⁴,Jensen Bjarne Anker³,Jensen Morten Krogh³,Kjeldsen Lars⁵,Klausen Tobias Wirenfeldt³,Larsen Herdis⁶,Mourits-Andersen Hans Torben⁷,Nielsen Claus Henrik²,Nielsen Ove Juul⁵,Plesner Torben⁸,Pulczynski Stanislaw⁹,Rasmussen Inge Helleberg¹⁰,Rønnov-Jessen Dorthe⁶,Hasselbalch Hans Carl¹

Affiliation:

1. Department of Hematology, Copenhagen University Hospital Roskilde, Roskilde, Denmark;

2. Department of Infectious Diseases and Rheumatology, Institute for Inflammation Research, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark;

3. Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark;

4. Department of Hematology, Odense University Hospital, Odense, Denmark;

5. Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark;

6. Department of Internal Medicine Hematology Section, Viborg Hospital, Viborg, Denmark;

7. Department of Hematology and Infectious Diseases, Esbjerg Hospital, Esbjerg, Denmark;

8. Department of Hematology, Vejle Hospital, Vejle, Denmark;

9. Department of Internal Medicine Hematology Section, Holstebro Hospital, Holstebro, Denmark; and

10. Department of Hematology Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

Abstract

Key Points In newly diagnosed ITP, addition of rituximab to dexamethasone yields higher sustained response rates than dexamethasone alone.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/11/1976/1363404/1976.pdf

Reference15 articles.

1. Pathogenesis of chronic immune thrombocytopenic purpura.;Cines;Curr Opin Hematol,2007

2. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.;Stasi;Thromb Haemost,2008

3. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts.;Cohen;Arch Intern Med,2000

4. International consensus report on the investigation and management of primary immune thrombocytopenia.;Provan;Blood,2010

5. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.;Arnold;Ann Intern Med,2007

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic and lymphoid abnormalities in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Differenzialdiagnose und Therapie der Immunthrombozytopenie;DMW - Deutsche Medizinische Wochenschrift;2024-07-16

3. Primary immune thrombocytopenic purpura with exuberant oral manifestations in a patient with Turner syndrome;Special Care in Dentistry;2024-07-11

4. Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective;Hematology Reports;2024-06-26

5. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial;Blood Advances;2024-03-18